About
Biologic for cardiovascular indications
Areas of Focus
Categories
Biologics & Biopharmaceutical
Team (4)
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
62
By Phase
PHASE2: 1PHASE1: 1
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05532735Lead Sponsor
Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Retinal Vein Occlusion
PHASE2Completed
16 participants
Started: Aug 24, 2022 · Completed: Nov 11, 2024
NCT04850339Lead Sponsor
First in Human Study of ANXV (Recombinant Human Annexin A5) in Healthy Volunteers
PHASE1Completed
46 participants
Started: Dec 21, 2020 · Completed: Oct 27, 2021
Locations (1)
Headquarters
Stockholm, Sweden
Map
Loading map...